Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,772 public trials 697 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)

NCT05192486

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
  • Affiliated Hospital of Hebei University Baoding, Hebei, China
  • The First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China
  • Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

NCT04446962

Conditions
Central Nervous System Neoplasms, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, +16 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CH côte Basque Bayonne, France
  • CHU Besançon Besançon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

NCT06285370

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Peking University First Hospital, Department of Dermatology and Venereology Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center, Department of Medical Oncology Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • The Affiliated Hospital of Inner Mongolia Medical University Hohhot, Inner Mongolia, China
View Trial Details
Active, Not Recruiting

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

NCT05471843

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
View all 104 locations
View Trial Details

Related conditions